Literature DB >> 14744811

Particular sensitivity to calcium channel blockers of the fast inward voltage-dependent sodium current involved in the invasive properties of a metastastic breast cancer cell line.

Sébastien Roger1, Jean-Yves Le Guennec, Pierre Besson.   

Abstract

1. A voltage-dependent sodium current has been described in the highly invasive breast cancer cell line MDA-MB-231. Its activity is associated with the invasive properties of the cells. The aim of our study was to test whether this current (I(Na)) is sensitive to three representative calcium channel blockers: verapamil, diltiazem and nifedipine. I(Na) was studied in patch-clamp conditions. 2. I(Na) was sensitive to verapamil (IC(50)=37.6+/-2.5 microM) and diltiazem (53.2+/-3.6 microM), while it was weakly sensitive to nifedipine. 3. The tetrodotoxin (TTX) concentration, which fully blocks I(Na) (30 microM), did not affect cell proliferation. Diltiazem and verapamil, at concentrations that do not fully block I(Na), strongly reduced cell proliferation, suggesting, regarding proliferation, that these molecules act on targets distinct from sodium channels. These targets are probably not other ionic channels, since the current measured at the end of a 500 ms long pulse in the voltage range between -60 and +40 mV was unaffected by verapamil and diltiazem. 4. We conclude that the sodium channel expressed in MDA-MB-231 cells is sensitive to several calcium channel blockers. The present study also underlines the danger of concluding to the possible involvement of membrane channel proteins in any phenomenon on the sole basis of pharmacology, and without an electrophysiological confirmation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744811      PMCID: PMC1574233          DOI: 10.1038/sj.bjp.0705649

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  23 in total

1.  Enhancement of voltage-gated Na+ channel current associated with multidrug resistance in human leukemia cells.

Authors:  N Yamashita; H Hamada; T Tsuruo; E Ogata
Journal:  Cancer Res       Date:  1987-07-15       Impact factor: 12.701

2.  Inhibition of ATP-sensitive potassium channels causes reversible cell-cycle arrest of human breast cancer cells in tissue culture.

Authors:  K A Woodfork; W F Wonderlin; V A Peterson; J S Strobl
Journal:  J Cell Physiol       Date:  1995-02       Impact factor: 6.384

3.  Does verapamil help overcome multidrug resistance in tumor cell lines and cancer patients?

Authors:  C V Timcheva; D K Todorov
Journal:  J Chemother       Date:  1996-08       Impact factor: 1.714

Review 4.  Multidrug resistance.

Authors:  J A Moscow; K H Cowan
Journal:  J Natl Cancer Inst       Date:  1988-03-02       Impact factor: 13.506

5.  Changes in membrane potential during the progression of MCF-7 human mammary tumor cells through the cell cycle.

Authors:  W F Wonderlin; K A Woodfork; J S Strobl
Journal:  J Cell Physiol       Date:  1995-10       Impact factor: 6.384

6.  Association between cell membrane potential and breast cancer.

Authors:  A A Marino; I G Iliev; M A Schwalke; E Gonzalez; K C Marler; C A Flanagan
Journal:  Tumour Biol       Date:  1994

Review 7.  Mitogenic signal transduction in human breast cancer cells.

Authors:  J S Strobl; W F Wonderlin; D C Flynn
Journal:  Gen Pharmacol       Date:  1995-12

8.  Multiple modulations of action potential duration by different calcium channel blocking agents in guinea pig ventricular myocytes.

Authors:  S Zhang; T Sawanobori; Y Hirano; M Hiraoka
Journal:  J Cardiovasc Pharmacol       Date:  1997-10       Impact factor: 3.105

9.  Verapamil inhibits tumor protease production, local invasion and metastasis development in murine carcinoma cells.

Authors:  E F Farías; J A Aguirre Ghiso; V Ladeda; E Bal de Kier Joffé
Journal:  Int J Cancer       Date:  1998-12-09       Impact factor: 7.396

10.  A novel benzothiazine Ca2+ channel antagonist, semotiadil, inhibits cardiac L-type Ca2+ currents.

Authors:  B Koidl; N Miyawaki; H A Tritthart
Journal:  Eur J Pharmacol       Date:  1997-03-19       Impact factor: 4.432

View more
  14 in total

1.  Ion channels as targets for cancer therapy.

Authors:  Minghua Li; Zhi-Gang Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-06-27

2.  On the biophysics of cathodal galvanotaxis in rat prostate cancer cells: Poisson-Nernst-Planck equation approach.

Authors:  Przemysław Borys
Journal:  Eur Biophys J       Date:  2012-03-31       Impact factor: 1.733

Review 3.  Targeting Ion Channels for Cancer Treatment: Current Progress and Future Challenges.

Authors:  Alina L Capatina; Dimitris Lagos; William J Brackenbury
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

Review 4.  Implicating anaesthesia and the perioperative period in cancer recurrence and metastasis.

Authors:  Julia A Dubowitz; Erica K Sloan; Bernhard J Riedel
Journal:  Clin Exp Metastasis       Date:  2017-09-11       Impact factor: 5.150

5.  SCN4B acts as a metastasis-suppressor gene preventing hyperactivation of cell migration in breast cancer.

Authors:  Emeline Bon; Virginie Driffort; Frédéric Gradek; Carlos Martinez-Caceres; Monique Anchelin; Pablo Pelegrin; Maria-Luisa Cayuela; Séverine Marionneau-Lambot; Thibauld Oullier; Roseline Guibon; Gaëlle Fromont; Jorge L Gutierrez-Pajares; Isabelle Domingo; Eric Piver; Alain Moreau; Julien Burlaud-Gaillard; Philippe G Frank; Stéphan Chevalier; Pierre Besson; Sébastien Roger
Journal:  Nat Commun       Date:  2016-12-05       Impact factor: 14.919

Review 6.  The prince and the pauper. A tale of anticancer targeted agents.

Authors:  Alfonso Dueñas-González; Patricia García-López; Luis Alonso Herrera; Jose Luis Medina-Franco; Aurora González-Fierro; Myrna Candelaria
Journal:  Mol Cancer       Date:  2008-10-23       Impact factor: 27.401

Review 7.  Voltage-gated sodium channels and cancer: is excitability their primary role?

Authors:  Sébastien Roger; Ludovic Gillet; Jean-Yves Le Guennec; Pierre Besson
Journal:  Front Pharmacol       Date:  2015-07-29       Impact factor: 5.810

8.  A voltage dependent non-inactivating Na+ channel activated during apoptosis in Xenopus oocytes.

Authors:  Ulrika H Englund; Jens Gertow; Katarina Kågedal; Fredrik Elinder
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

9.  Ranolazine inhibits NaV1.5-mediated breast cancer cell invasiveness and lung colonization.

Authors:  Virginie Driffort; Ludovic Gillet; Emeline Bon; Séverine Marionneau-Lambot; Thibauld Oullier; Virginie Joulin; Christine Collin; Jean-Christophe Pagès; Marie-Lise Jourdan; Stéphan Chevalier; Philippe Bougnoux; Jean-Yves Le Guennec; Pierre Besson; Sébastien Roger
Journal:  Mol Cancer       Date:  2014-12-11       Impact factor: 27.401

Review 10.  Therapeutic Value of Voltage-Gated Sodium Channel Inhibitors in Breast, Colorectal, and Prostate Cancer: A Systematic Review.

Authors:  Fabiola Martin; Chiedu Ufodiama; Ian Watt; Martin Bland; William J Brackenbury
Journal:  Front Pharmacol       Date:  2015-11-12       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.